Maguire A, Arellano Felix M, Perez-Gutthann S, Arana A. Risk benefit modeling: the use of stochastic simulation for safety evaluations. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(Suppl 1):S272.
Arana A, Castellsague J, Trave F, Perez-Gutthann S, Rothman KJ, Arellano FM. Early estimation of excess risk of serious cutaneous reactions for newly marketed drugs. Poster presented at the 1st International Conference on Therapeutic Risk Management & 19th ICPE International Conference on Pharmacoepidemiology; August 2003. Philadelphia, PA. [abstract] Pharmacoepidemiol Drug Saf. 2003 Aug; 12(S1):165.
Tuells A, Arana A, Perez-Gutthann S, García-Rodríguez LA. El Proyecto BIFAP. Inv Clin Farm. 2003;0:25-6.
Arana A, Gutierrez L, Garcia-Rodriguez LA, Perez-Gutthann S. Antiepileptics and liver, testes, cervix uteri and vulvar cancer: a cohort study. Poster presented at the 17th International Conference on Pharmacoepidemiology; August 2001. Toronto, Canada. [abstract] Pharmacoepidemiol Drug Saf. 2001 Aug; 10(supp 1):128.
Arana A, Castellsague J, Tognoni G, Perez-Gutthann S. Individual daily questionnaires in pharmacoepidemiologic studies and ways of analyzing recurrent events. Comparing tolerability of Desferal® in a real-life setting. Presented at the 13th International Conference on Pharmacoepidemiology; 1997. Orlando, FL. [abstract] Pharmacoepidemiol Drug Saf. 1997 Aug; 6(S2).